Nifty

:

21995.85

Sensex

:

72488.99

-152.05 (-0.69%)
-454.69 (-0.62%)

Login

Nifty
Sensex

:
:

21995.85
72488.99

-152.05 (-0.69%)
-454.69 (-0.62%)

Orchid Pharma Ltd.

Pharmaceuticals & Drugs

Rating :

64/99

BSE: 524372 | NSE: ORCHPHARMA

Watchlist

NSE BSE

1071.20

18-Apr-2024

Open
High
Low
Previous Close

1119.00
1122.40
1066.00
1100.40

Volume
Traded Value (lacs)
52 Week High
52 Week Low

40265
438.99
1359.95
372.65

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

5,461.69
46.37
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

5,557.86
N/A
4.80

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
2.11
13.95

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
10.72

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-4.46
-

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

2.10
2.43
2.86

EV:EBITDA (Average)

8 Years
5 Years
3 Years

0.84
-24.68
45.41

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 220.59 159.76 38.08% 198.75 165.25 20.27% 182.92 130.99 39.64% 209.90 180.23 16.46%
Expenses 184.68 146.10 26.41% 175.06 147.43 18.74% 160.78 118.54 35.63% 170.21 150.76 12.90%
EBITDA 35.91 13.66 162.88% 23.70 17.82 33.00% 22.14 12.45 77.83% 39.69 29.48 34.63%
EBIDTM 16.28% 8.55% 11.92% 10.79% 12.10% 9.50% 18.91% 16.36%
Other Income 7.44 8.93 -16.69% 8.18 5.84 40.07% 1.89 2.93 -35.49% 1.73 1.75 -1.14%
Interest 3.54 7.68 -53.91% 3.80 9.22 -58.79% 5.54 7.84 -29.34% 7.48 4.46 67.71%
Depreciation 9.27 8.18 13.33% 7.84 17.76 -55.86% 7.71 21.63 -64.36% 7.21 26.63 -72.93%
PBT 30.54 6.73 353.79% 20.24 -3.32 - 10.78 -14.09 - 65.93 0.14 46,992.86%
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 30.54 6.73 353.79% 20.24 -3.32 - 10.78 -14.09 - 65.93 0.14 46,992.86%
PATM 13.85% 4.21% 10.18% -2.01% 5.89% -10.76% 31.41% 0.08%
EPS 6.02 1.33 352.63% 3.99 -0.66 - 2.13 -2.78 - 13.00 0.03 43,233.33%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 220.59 159.76 38.08% 198.75 165.25 20.27% 182.92 130.99 39.64% 209.90 178.13 17.84%
Expenses 185.20 146.10 26.76% 175.44 147.43 19.00% 160.78 118.54 35.63% 170.21 152.37 11.71%
EBITDA 35.39 13.66 159.08% 23.31 17.82 30.81% 22.14 12.45 77.83% 39.69 25.77 54.02%
EBIDTM 16.04% 8.55% 11.73% 10.79% 12.11% 9.50% 18.91% 14.46%
Other Income 7.62 8.93 -14.67% 8.36 5.84 43.15% 1.89 2.93 -35.49% 1.73 1.75 -1.14%
Interest 3.54 7.68 -53.91% 3.80 9.22 -58.79% 5.54 7.84 -29.34% 7.48 4.46 67.71%
Depreciation 9.27 8.18 13.33% 7.84 17.76 -55.86% 7.71 21.63 -64.36% 7.21 26.62 -72.92%
PBT 30.19 6.73 348.59% 20.02 -3.32 - 10.78 -14.09 - 65.93 -3.57 -
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 30.19 6.73 348.59% 20.02 -3.32 - 10.78 -14.09 - 65.93 -3.57 -
PATM 13.69% 4.21% 10.07% -2.01% 5.89% -10.76% 31.41% -2.00%
EPS 5.80 1.86 211.83% 3.90 -1.32 - 1.85 -3.68 - 14.49 -1.61 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Sep 13
Net Sales 812.16 665.90 556.97 450.69 481.21 583.65 644.17 755.36 879.34 1,736.19 1,906.58 Net Sales Growth 27.65% 19.56% 23.58% -6.34% -17.55% -9.40% -14.72% -14.10% -49.35% -8.94% Cost Of Goods Sold 475.23 384.62 314.07 229.27 200.31 278.16 330.87 367.46 419.31 781.33 958.27 Gross Profit 336.93 281.28 242.90 221.42 280.90 305.49 313.30 387.89 460.03 954.86 948.32 GP Margin 41.49% 42.24% 43.61% 49.13% 58.37% 52.34% 48.64% 51.35% 52.32% 55.00% 49.74% Total Expenditure 690.73 581.60 498.27 391.92 531.19 589.95 621.96 663.28 705.28 1,416.33 1,776.74 Power & Fuel Cost - 61.26 52.74 39.31 47.44 48.76 50.69 54.33 55.28 102.19 121.72 % Of Sales - 9.20% 9.47% 8.72% 9.86% 8.35% 7.87% 7.19% 6.29% 5.89% 6.38% Employee Cost - 65.35 60.21 64.40 71.60 79.14 82.39 75.44 82.63 185.79 237.05 % Of Sales - 9.81% 10.81% 14.29% 14.88% 13.56% 12.79% 9.99% 9.40% 10.70% 12.43% Manufacturing Exp. - 35.55 32.88 29.09 50.71 54.64 63.08 85.12 91.48 182.20 223.51 % Of Sales - 5.34% 5.90% 6.45% 10.54% 9.36% 9.79% 11.27% 10.40% 10.49% 11.72% General & Admin Exp. - 14.26 10.80 15.23 42.43 28.21 38.52 38.42 28.04 88.13 92.49 % Of Sales - 2.14% 1.94% 3.38% 8.82% 4.83% 5.98% 5.09% 3.19% 5.08% 4.85% Selling & Distn. Exp. - 14.34 20.35 11.52 6.42 7.40 14.62 35.43 21.35 48.59 48.33 % Of Sales - 2.15% 3.65% 2.56% 1.33% 1.27% 2.27% 4.69% 2.43% 2.80% 2.53% Miscellaneous Exp. - 6.22 7.22 3.10 112.29 93.64 41.79 7.07 7.19 28.11 48.33 % Of Sales - 0.93% 1.30% 0.69% 23.33% 16.04% 6.49% 0.94% 0.82% 1.62% 5.00% EBITDA 121.44 84.30 58.70 58.77 -49.98 -6.30 22.21 92.08 174.06 319.86 129.84 EBITDA Margin 14.95% 12.66% 10.54% 13.04% -10.39% -1.08% 3.45% 12.19% 19.79% 18.42% 6.81% Other Income 19.24 19.43 9.00 6.46 24.28 16.93 19.87 19.48 24.60 42.37 39.77 Interest 20.36 32.90 33.46 52.21 6.22 6.68 310.25 331.10 294.23 537.01 520.38 Depreciation 32.03 54.79 87.02 108.90 117.91 129.92 133.29 139.42 143.41 321.37 243.87 PBT 127.49 16.04 -52.77 -95.87 -149.84 -125.99 -401.47 -358.96 -238.98 -496.15 -594.63 Tax 0.00 0.00 0.00 0.00 0.00 0.00 -46.19 -48.04 -17.25 -191.75 -13.30 Tax Rate 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 11.51% 9.04% 5.92% 50.09% 2.45% PAT 127.49 55.25 -52.77 -95.87 -149.84 -101.05 -355.28 -483.63 -274.27 -191.04 -530.23 PAT before Minority Interest 127.49 55.25 -52.77 -95.87 -149.84 -101.05 -355.28 -483.63 -274.27 -191.04 -530.23 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 15.70% 8.30% -9.47% -21.27% -31.14% -17.31% -55.15% -64.03% -31.19% -11.00% -27.81% PAT Growth 1,309.58% - - - - - - - - - EPS 25.15 10.90 -10.41 -18.91 -29.55 -19.93 -70.07 -95.39 -54.10 -37.68 -104.58

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Sep 13
Net Sales 812.16 665.90 559.56 450.06 483.80 599.98 682.98 796.50 873.44 1,746.61 1,947.70 Net Sales Growth 28.07% 19.00% 24.33% -6.97% -19.36% -12.15% -14.25% -8.81% -49.99% -10.32% Cost Of Goods Sold 475.23 384.62 313.56 228.51 203.35 289.70 350.20 393.46 400.96 779.03 990.12 Gross Profit 336.93 281.28 246.00 221.56 280.45 310.28 332.79 403.05 472.47 967.58 957.58 GP Margin 41.49% 42.24% 43.96% 49.23% 57.97% 51.72% 48.73% 50.60% 54.09% 55.40% 49.16% Total Expenditure 691.63 581.60 504.98 399.40 514.99 611.80 658.68 709.37 702.65 1,429.32 1,837.44 Power & Fuel Cost - 61.26 52.74 39.31 47.44 48.76 50.69 54.33 55.28 102.19 121.72 % Of Sales - 9.20% 9.43% 8.73% 9.81% 8.13% 7.42% 6.82% 6.33% 5.85% 6.25% Employee Cost - 65.35 63.28 67.11 74.86 82.28 86.22 80.25 86.81 193.82 252.70 % Of Sales - 9.81% 11.31% 14.91% 15.47% 13.71% 12.62% 10.08% 9.94% 11.10% 12.97% Manufacturing Exp. - 35.55 32.88 29.10 53.25 55.98 65.65 87.40 94.33 182.40 226.41 % Of Sales - 5.34% 5.88% 6.47% 11.01% 9.33% 9.61% 10.97% 10.80% 10.44% 11.62% General & Admin Exp. - 14.26 13.03 18.34 43.67 30.72 41.49 40.99 31.10 91.62 93.40 % Of Sales - 2.14% 2.33% 4.08% 9.03% 5.12% 6.07% 5.15% 3.56% 5.25% 4.80% Selling & Distn. Exp. - 14.34 22.26 13.46 8.14 10.34 22.10 45.73 27.73 51.28 55.52 % Of Sales - 2.15% 3.98% 2.99% 1.68% 1.72% 3.24% 5.74% 3.17% 2.94% 2.85% Miscellaneous Exp. - 6.22 7.22 3.59 84.27 94.02 42.34 7.21 6.44 28.97 55.52 % Of Sales - 0.93% 1.29% 0.80% 17.42% 15.67% 6.20% 0.91% 0.74% 1.66% 5.01% EBITDA 120.53 84.30 54.58 50.66 -31.19 -11.82 24.30 87.13 170.79 317.29 110.26 EBITDA Margin 14.84% 12.66% 9.75% 11.26% -6.45% -1.97% 3.56% 10.94% 19.55% 18.17% 5.66% Other Income 19.60 19.43 9.00 15.21 24.28 16.93 20.30 19.17 24.91 42.47 40.72 Interest 20.36 32.90 33.46 52.21 6.23 6.69 310.26 331.11 294.24 537.12 522.69 Depreciation 32.03 54.79 87.02 108.92 117.93 129.94 133.31 141.02 145.27 324.58 251.92 PBT 126.92 16.04 -56.90 -95.25 -131.07 -131.52 -398.96 -365.82 -243.82 -501.95 -623.63 Tax 0.00 0.00 0.00 0.00 0.00 0.00 -46.19 -48.04 -17.25 -191.46 -12.52 Tax Rate 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 11.58% 8.92% 5.82% 49.27% 2.19% PAT 126.92 55.25 -56.90 -95.25 -131.07 69.41 -352.77 -490.49 -279.11 -196.51 -558.02 PAT before Minority Interest 126.92 55.25 -56.90 -95.25 -131.07 69.41 -352.77 -490.49 -279.11 -197.13 -559.99 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.62 1.97 PAT Margin 15.63% 8.30% -10.17% -21.16% -27.09% 11.57% -51.65% -61.58% -31.96% -11.25% -28.65% PAT Growth 990.67% - - - - - - - - - EPS 25.03 10.90 -11.22 -18.79 -25.85 13.69 -69.58 -96.74 -55.05 -38.76 -110.06

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 731.96 677.95 681.34 797.83 -754.99 -674.13 -263.83 171.13 439.40 488.17 Share Capital 40.82 40.82 40.82 40.82 88.96 88.96 88.96 88.96 85.26 70.45 Total Reserves 691.15 637.14 640.52 757.01 -843.95 -763.10 -352.80 82.17 354.14 417.71 Non-Current Liabilities 164.67 222.40 442.26 518.98 1,435.53 1,904.62 2,204.95 2,475.41 2,609.53 1,064.91 Secured Loans 40.09 110.84 341.60 429.50 1,424.61 1,893.91 2,156.78 2,377.54 2,493.95 901.78 Unsecured Loans 108.75 97.32 85.90 74.47 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 12.60 11.01 11.54 11.79 7.70 7.48 2.07 3.73 4.18 5.24 Current Liabilities 326.63 193.83 100.87 133.18 2,312.71 1,980.28 1,519.64 1,315.98 1,107.10 3,170.14 Trade Payables 136.52 120.74 68.74 60.21 269.93 326.85 403.68 353.09 295.85 561.67 Other Current Liabilities 45.67 47.25 25.76 69.72 1,343.66 958.10 476.00 285.05 112.37 1,052.40 Short Term Borrowings 140.95 22.84 2.84 0.00 695.49 694.29 599.52 633.62 646.64 1,524.89 Short Term Provisions 3.49 3.01 3.52 3.25 3.63 1.03 40.44 44.22 52.23 31.17 Total Liabilities 1,223.26 1,094.18 1,224.47 1,449.99 2,993.25 3,210.77 3,460.76 3,962.52 4,156.03 4,723.22 Net Block 573.06 583.65 670.39 857.86 1,161.35 1,291.28 1,401.71 1,540.36 1,697.10 2,482.81 Gross Block 1,220.45 1,176.26 1,175.97 1,246.98 1,424.57 1,424.57 2,893.25 2,893.19 2,889.70 3,659.71 Accumulated Depreciation 647.39 592.60 505.58 389.12 263.22 133.29 1,491.54 1,352.83 1,192.60 1,176.90 Non Current Assets 729.46 711.12 682.22 885.22 2,209.79 2,519.97 2,507.72 2,638.40 2,809.23 3,571.52 Capital Work in Progress 46.09 9.78 7.43 25.61 278.16 271.53 288.31 280.40 281.51 360.42 Non Current Investment 50.12 49.01 0.40 0.34 0.47 124.77 124.66 124.65 124.65 124.18 Long Term Loans & Adv. 60.20 68.66 3.98 1.41 759.97 822.41 685.17 680.99 681.85 576.08 Other Non Current Assets 0.00 0.01 0.01 0.00 9.84 9.98 7.88 12.00 24.12 28.04 Current Assets 493.79 369.78 542.25 564.77 783.46 690.80 953.03 1,324.12 1,346.79 1,151.69 Current Investments 0.00 0.00 15.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 228.74 172.66 150.57 140.78 167.11 184.94 197.45 210.34 242.28 500.08 Sundry Debtors 211.91 160.23 131.96 66.38 140.73 145.06 246.42 375.44 290.16 183.70 Cash & Bank 22.34 4.21 18.97 172.32 324.17 301.04 256.04 313.11 389.57 22.40 Other Current Assets 30.81 12.86 130.11 21.34 151.45 59.75 253.12 425.23 424.78 445.51 Short Term Loans & Adv. 27.17 19.83 95.63 163.95 127.86 40.31 244.22 308.82 319.26 431.67 Net Current Assets 167.16 175.95 441.38 431.59 -1,529.25 -1,289.49 -566.61 8.14 239.69 -2,018.45 Total Assets 1,223.25 1,080.90 1,224.47 1,449.99 2,993.25 3,210.77 3,460.75 3,962.52 4,156.02 4,723.21

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Sep 13
Shareholder's Funds 688.65 647.38 652.91 765.98 -704.04 -791.76 -387.67 49.04 329.39 379.99 Share Capital 40.82 40.82 40.82 40.82 88.96 88.96 88.96 88.96 85.26 70.45 Total Reserves 647.83 606.56 612.09 725.17 -793.00 -880.72 -476.63 -39.92 244.12 309.53 Non-Current Liabilities 164.67 222.40 442.26 518.98 1,435.53 1,904.62 2,204.95 2,475.41 2,609.35 1,064.40 Secured Loans 40.09 110.84 341.60 429.50 1,424.61 1,893.91 2,156.78 2,377.54 2,493.95 901.79 Unsecured Loans 108.75 97.32 85.90 74.47 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 12.60 11.01 11.54 11.79 7.70 7.48 2.07 3.73 4.18 5.24 Current Liabilities 371.89 240.78 142.08 174.94 2,345.54 2,012.51 1,540.72 1,337.62 1,122.66 3,206.03 Trade Payables 181.78 167.68 109.95 101.59 302.45 358.79 424.52 374.27 311.15 597.40 Other Current Liabilities 45.67 47.25 25.76 70.10 1,343.97 958.40 476.24 285.34 112.64 1,052.57 Short Term Borrowings 140.95 22.84 2.84 0.00 695.49 694.29 599.52 633.79 646.64 1,524.89 Short Term Provisions 3.49 3.01 3.52 3.25 3.63 1.03 40.44 44.22 52.23 31.17 Total Liabilities 1,225.21 1,110.56 1,237.25 1,459.90 3,077.03 3,125.37 3,358.00 3,862.07 4,061.40 4,651.04 Net Block 573.09 583.70 670.45 857.93 1,256.26 1,386.20 1,496.54 1,636.83 1,795.20 2,583.57 Gross Block 1,220.56 1,176.39 1,176.10 1,247.11 1,519.52 1,519.16 3,005.92 3,005.87 3,002.15 3,772.17 Accumulated Depreciation 647.47 592.68 505.66 389.18 263.26 132.96 1,509.38 1,369.04 1,206.95 1,188.60 Non Current Assets 724.20 712.91 687.39 890.58 2,309.57 2,446.42 2,478.86 2,610.87 2,783.27 3,549.62 Capital Work in Progress 46.46 9.78 7.43 25.61 278.16 271.53 288.31 280.40 281.51 360.42 Non Current Investment 44.44 45.49 0.40 0.34 0.47 1.07 0.96 0.81 0.81 0.95 Long Term Loans & Adv. 60.20 73.93 9.10 6.70 764.84 777.64 685.17 680.83 681.63 576.08 Other Non Current Assets 0.00 0.01 0.01 0.00 9.84 9.98 7.88 12.00 24.12 28.60 Current Assets 501.01 384.36 549.86 569.32 767.46 678.94 879.14 1,251.20 1,278.12 1,101.42 Current Investments 0.00 0.00 15.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 228.74 172.66 152.89 141.69 169.77 193.74 211.25 241.85 251.93 506.24 Sundry Debtors 215.19 170.57 135.70 67.97 119.89 119.51 203.00 310.07 256.57 179.06 Cash & Bank 30.63 8.06 19.91 174.04 325.52 305.55 257.06 314.94 390.56 23.42 Other Current Assets 26.45 13.01 130.47 21.57 152.28 60.14 207.82 384.34 379.06 392.69 Short Term Loans & Adv. 22.50 20.07 95.87 164.05 140.27 40.31 198.36 267.62 273.26 378.34 Net Current Assets 129.12 143.58 407.78 394.39 -1,578.08 -1,333.57 -661.58 -86.42 155.46 -2,104.61 Total Assets 1,225.21 1,097.27 1,237.25 1,459.90 3,077.03 3,125.36 3,358.00 3,862.07 4,061.39 4,651.04

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Sep 13
Cash From Operating Activity 13.39 89.57 24.36 80.42 15.18 5.58 317.68 211.30 -369.72 174.91 PBT 54.19 -4.81 -117.15 -149.84 -101.05 -401.47 -445.42 -291.52 -237.53 -543.52 Adjustment 54.10 38.24 163.69 174.58 235.19 449.77 575.53 495.56 999.29 709.11 Changes in Working Capital -94.60 58.04 -27.10 45.25 -114.68 -35.68 187.56 7.26 -668.57 9.33 Cash after chg. in Working capital 13.69 91.47 19.44 70.00 19.46 12.62 317.68 211.30 93.18 174.91 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.30 -1.91 4.92 10.42 -4.28 -7.04 0.00 0.00 -47.03 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -415.87 0.00 Cash From Investing Activity -26.70 112.93 67.21 167.12 45.48 -27.95 -8.62 -1.23 1,334.21 -997.95 Net Fixed Assets -80.50 -2.64 89.19 430.14 -6.63 1,485.46 -7.97 -2.38 848.92 -751.02 Net Investments -1.11 -33.59 -15.08 0.13 124.30 -0.11 -0.01 0.00 -0.47 24.72 Others 54.91 149.16 -6.90 -263.15 -72.19 -1,513.30 -0.64 1.15 485.76 -271.65 Cash from Financing Activity 31.17 -216.80 -164.99 -250.33 -0.30 33.39 -366.12 -286.52 -597.32 675.85 Net Cash Inflow / Outflow 17.86 -14.30 -73.42 -2.79 60.36 11.02 -57.07 -76.45 367.17 -147.19 Opening Cash & Equivalents 0.45 14.75 88.17 90.97 30.60 19.58 313.11 389.57 22.40 169.59 Closing Cash & Equivalent 18.31 0.45 14.75 88.17 90.97 30.60 256.04 313.11 389.57 22.40

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Sep 13
Cash From Operating Activity 18.34 92.47 23.59 80.80 12.02 9.18 317.01 212.20 -369.07 168.17 PBT 46.32 -1.95 -116.53 -131.07 69.41 -398.96 -452.28 -296.18 -243.29 -572.51 Adjustment 51.38 36.77 172.15 139.57 57.34 453.49 582.11 490.19 1,006.39 661.19 Changes in Working Capital -79.06 59.57 -36.96 61.89 -110.44 -38.31 187.17 18.19 -669.27 79.49 Cash after chg. in Working capital 18.64 94.38 18.66 70.38 16.30 16.22 317.01 212.20 93.84 168.17 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.30 -1.91 4.92 10.42 -4.28 -7.04 0.00 0.00 -47.03 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -415.87 0.00 Cash From Investing Activity -31.21 112.94 67.21 167.11 45.47 -28.06 -8.59 -1.46 1,333.66 -986.04 Net Fixed Assets -80.50 -2.64 89.19 430.14 -6.63 1,485.46 -7.97 -2.38 848.92 -751.02 Net Investments -1.11 -33.59 -15.08 0.13 124.30 -0.11 -0.01 0.00 -0.47 24.72 Others 50.40 149.17 -6.90 -263.16 -72.20 -1,513.41 -0.61 0.92 485.21 -259.74 Cash from Financing Activity 31.17 -216.80 -164.99 -250.33 -0.30 33.39 -366.30 -286.36 -597.44 664.38 Net Cash Inflow / Outflow 18.29 -11.39 -74.20 -2.42 57.20 14.51 -57.88 -75.62 367.14 -153.49 Opening Cash & Equivalents 4.31 15.69 89.89 92.31 35.11 20.60 314.94 390.56 23.42 176.92 Closing Cash & Equivalent 22.60 4.31 15.69 89.89 92.31 35.11 257.06 314.94 390.56 23.42

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Sep 13
Book Value (Rs.) 179.33 166.10 166.93 195.47 -84.86 -75.78 -29.66 19.24 51.54 69.29 ROA 4.77% -4.55% -7.17% -6.74% -3.26% -10.65% -13.03% -6.76% -4.30% -12.30% ROE 7.84% -7.76% -12.96% -699.60% 0.00% 0.00% 0.00% -89.85% -41.19% -64.88% ROCE 8.77% -1.86% -3.50% -7.48% -3.77% -3.40% -6.44% 0.08% 4.20% -0.68% Fixed Asset Turnover 0.56 0.47 0.37 0.36 0.41 0.30 0.26 0.31 0.53 0.58 Receivable days 101.99 95.74 80.31 78.55 89.36 110.08 148.10 136.50 49.54 26.16 Inventory Days 110.01 105.91 117.98 116.77 110.08 107.53 97.12 92.83 77.61 106.90 Payable days 122.07 110.10 102.64 113.51 182.54 192.92 181.33 144.12 82.15 97.04 Cash Conversion Cycle 89.93 91.55 95.64 81.81 16.91 24.69 63.90 85.21 45.00 36.02 Total Debt/Equity 0.45 0.40 0.66 0.71 -4.28 -4.75 -11.77 18.78 7.31 6.56 Interest Cover 2.68 -0.58 -0.84 -23.07 -14.12 -0.29 -0.61 0.01 0.29 -0.04

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Sep 13
Book Value (Rs.) 168.72 158.61 159.96 187.67 -79.14 -89.00 -43.58 5.51 38.63 53.94 ROA 4.73% -4.85% -7.06% -5.78% 2.24% -10.88% -13.59% -7.05% -4.53% -13.04% ROE 8.27% -8.75% -13.43% -423.17% 0.00% 0.00% 0.00% -147.51% -55.58% -74.06% ROCE 9.11% -2.32% -3.53% -6.47% 3.08% -3.46% -6.93% -0.06% 4.17% -1.48% Fixed Asset Turnover 0.56 0.48 0.37 0.35 0.39 0.30 0.27 0.29 0.52 0.57 Receivable days 105.72 99.89 82.59 70.86 72.82 85.57 115.97 116.98 45.27 27.22 Inventory Days 110.01 106.18 119.45 117.49 110.57 107.46 102.41 101.94 78.79 109.43 Payable days 165.82 161.59 168.95 136.49 197.80 198.57 186.30 148.72 86.46 100.90 Cash Conversion Cycle 49.91 44.47 33.09 51.86 -14.40 -5.54 32.07 70.20 37.60 35.76 Total Debt/Equity 0.48 0.41 0.69 0.74 -4.59 -4.04 -8.01 65.54 9.75 8.43 Interest Cover 2.68 -0.70 -0.82 -20.04 11.38 -0.29 -0.63 -0.01 0.28 -0.10

Top Investors:

quant mutual fund - quant small cap fund

massachusetts institute of technology

quant mutual fund quant multi asset fund

max life insurance company limited a/c - ulif00225/06/04lifebalanc104 - balanced fund

nippon life india trustee ltd - a/c nippon indian pharma fund

quant mutual fund quant value fund

carnelian structural shift fund

uti - healthcare fund

Annual Reports:

News Update:

Orchid Pharma - Quarterly Results
8th Feb 2024, 15:54 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback